Blend Labs, Inc.
For the period ended Dec 31, 2025. Filed Mar 16, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 16, 2026
BLND$1.08+9.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $43,578 | $38,011 |
| Marketable securities and other investments | 24,739 | 56,233 |
| Trade and other receivables, net of allowance for credit losses of $112 and $50, respectively | 8,786 | 14,656 |
| Prepaid expenses and other current assets | 15,121 | 16,725 |
| Current assets held for sale from discontinued operations | 5,640 | 9,618 |
| Total current assets | 97,864 | 135,243 |
| Property and equipment, net | 22,997 | 11,672 |
| Operating lease right-of-use assets | 1,394 | 339 |
| Deferred contract costs | 3,425 | 2,868 |
| Other non-current assets | 41,425 | 21,906 |
| Non-current assets held for sale from discontinued operations | 2,940 | 6,057 |
| Total assets | $170,045 | $178,085 |
| Liabilities, redeemable equity and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $1,826 | $1,620 |
| Deferred revenue | 19,385 | 19,240 |
| Accrued compensation | 4,555 | 3,315 |
| Other current liabilities | 8,872 | 9,740 |
| Current liabilities held for sale from discontinued operations | 4,816 | 5,107 |
| Total current liabilities | 39,454 | 39,022 |
| Other non-current liabilities | 1,415 | 278 |
| Non-current liabilities held for sale from discontinued operations | 154 | 1,103 |
| Total liabilities | 41,023 | 40,403 |
| Commitments and contingencies (Note 7) | ||
| Redeemable noncontrolling interest - held for sale from discontinued operations | — | 52,375 |
| Series A redeemable convertible preferred stock, par value $0.00001 per share: 200,000 shares authorized as of December 31, 2025 and 2024, 150 shares issued and outstanding as of December 31, 2025 and 2024, respectively (Note 9) | 159,495 | 141,663 |
| Stockholders’ equity: | ||
| Class A, Class B and Class C Common Stock, par value $0.00001 per share: 3,000,000 (Class A 1,800,000, Class B 600,000, Class C 600,000) shares authorized as of December 31, 2025 and 2024; 256,043 (Class A 252,787, Class B 3,256, Class C 0) and 258,173 (Class A 254,426, Class B 3,747, Class C 0) shares issued and outstanding as of December 31, 2025 and 2024, respectively | 2 | 2 |
| Additional paid-in capital | 1,360,704 | 1,328,015 |
| Accumulated other comprehensive income | 597 | 602 |
| Accumulated deficit | (1,391,776) | (1,384,975) |
| Total stockholders’ equity | (30,473) | (56,356) |
| Total liabilities, redeemable equity and stockholders’ equity | $170,045 | $178,085 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.